Brookline Capital Markets Downgrades Annovis Bio Inc. (ANVS) to Hold 'on Ph.3 PD Trial Uncertainty'
Tweet Send to a Friend
(Updated - February 28, 2024 6:24 AM EST)
Brookline Capital Markets analyst Tyler Bussian downgraded Annovis Bio Inc. (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Brookline Capital Markets analyst Tyler Bussian downgraded Annovis Bio Inc. (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
